Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

被引:153
|
作者
Adkins, Irena [1 ,2 ,3 ]
Fucikova, Jitka [1 ,2 ,3 ]
Garg, Abhishek D. [4 ]
Agostinis, Patrizia [4 ]
Spisek, Radek [1 ,2 ,3 ]
机构
[1] Sotio, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic
[3] Charles Univ Prague, Univ Hosp Motol, Prague, Czech Republic
[4] Univ Leuven KU Leuven, Dept Mol & Cell Biol, Cell Death Res & Therapy CDRT Unit, Leuven, Belgium
来源
ONCOIMMUNOLOGY | 2014年 / 3卷 / 12期
关键词
cancer immunotherapy; high hydrostatic pressure; hyperthermia; immunogenic cell death; ionizing irradiation; photodynamic therapy with hypericin; HIGH HYDROSTATIC-PRESSURE; DISTANT UNTREATED TUMORS; REGULATORY T-CELLS; PHOTODYNAMIC-THERAPY; DENDRITIC CELLS; CALRETICULIN EXPOSURE; ANTITUMOR IMMUNITY; ER STRESS; INTRACELLULAR HYPERTHERMIA; IONIZING IRRADIATION;
D O I
10.4161/21624011.2014.968434
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The concept of immunogenic cancer cell death (ICD), as originally observed during the treatment with several chemotherapeutics or ionizing irradiation, has revolutionized the view on the development of new anticancer therapies. ICD is defined by endoplasmic reticulum (ER) stress response, reactive oxygen species (ROS) generation, emission of danger-associated molecular patterns and induction of antitumor immunity. Here we describe known and emerging cancer cell death-inducing physical modalities, such as ionizing irradiation, ultraviolet C light, Photodynamic Therapy (PDT) with Hypericin, high hydrostatic pressure (HHP) and hyperthermia (HT), which have been shown to elicit effective antitumor immunity. We discuss the evidence of ICD induced by these modalities in cancer patients together with their applicability in immunotherapeutic protocols and anticancer vaccine development.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Sensitize Tumor Immunotherapy: Immunogenic Cell Death Inducing Nanosystems
    Peng, Jianlan
    Li, Shiying
    Ti, Huihui
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 5895 - 5930
  • [2] Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy
    Zhang, Shenwu
    Wang, Jing
    Kong, Zhiqiang
    Sun, Xinxin
    He, Zhonggui
    Sun, Bingjun
    Luo, Cong
    Sun, Jin
    BIOMATERIALS, 2022, 282
  • [3] Immunogenic cell death in cancer immunotherapy
    Choi, Minji
    Shin, Jisoo
    Lee, Chae-Eun
    Chung, Joo-Yoon
    Kim, Minji
    Yan, Xiuwen
    Yang, Wen-Hao
    Cha, Jong-Ho
    BMB REPORTS, 2023, 56 (05) : 275 - 286
  • [4] The inducers of immunogenic cell death for tumor immunotherapy
    Li, Xiuying
    TUMORI JOURNAL, 2018, 104 (01): : 1 - 8
  • [5] Immunogenic cell death-inducing small molecule inhibitors: Potential for immunotherapy of cancer
    Guo, Zong Sheng
    Kalinski, Pawel
    Chen, Hongqi
    Zhu, Zhi
    CLINICAL AND TRANSLATIONAL DISCOVERY, 2022, 2 (02):
  • [6] Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death
    Liu, Kecheng
    Chen, Yutong
    Li, Bixiang
    Li, Yaning
    Liang, Xinyue
    Lin, Hai
    Luo, Lisi
    Chen, Tianliang
    Dai, Yalan
    Pang, Wenzheng
    Zeng, Linjuan
    BIOMOLECULES, 2023, 13 (03)
  • [7] Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy
    Li, Cong
    Wang, Lihong
    Li, Zhihang
    Li, Zehao
    Zhang, Kexin
    Cao, Lianrui
    Wang, Zeyu
    Shen, Chao
    Chen, Lijiang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 651
  • [8] Immunogenic cell death modalities and their impact on cancer treatment
    Kepp, Oliver
    Tesniere, Antoine
    Schlemmer, Frederic
    Michaud, Mickael
    Senovilla, Laura
    Zitvogel, Laurence
    Kroemer, Guido
    APOPTOSIS, 2009, 14 (04) : 364 - 375
  • [9] Advances in Immunogenic Cell Death for Cancer Immunotherapy
    Ding, Dan
    Jiang, Xiqun
    SMALL METHODS, 2023, 7 (05)
  • [10] Targeting immunogenic cell death for cancer immunotherapy
    Qingfei Zhang
    Lu Fan
    Gaizhen Kuang
    Yuanjin Zhao
    Medicine Plus, 2024, 1 (01) : 18 - 22